Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease

Movement Disorders

Volumn 20, Issue 12, 2005, Pages 1658-1661

  Walshe, John M ^a,b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Acaeruloplasminemia; Diagnosis; Serum caeruloplasmin; Wilson disease

Indexed keywords

CERULOPLASMIN; BIOLOGICAL MARKER; COPPER;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ACERULOPLASMINEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HALLERVORDEN SPATZ DISEASE; HUMAN; HUNTINGTON CHOREA; LABORATORY DIAGNOSIS; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBACUTE SCLEROSING PANENCEPHALITIS; WILSON DISEASE; BLOOD; CHILD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; NEUROLOGIC DISEASE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CERULOPLASMIN; CHILD; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES;

EID: 33644936760     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20628     Document Type: Article

References (21)

1. Bearn AG, Kunkel HG. Biochemical abnormalities in Wilson's disease. J Clin Invest 1952;31:616.
2. Scheinberg IH, Gitlin D. Deficiency of caeruloplasmin in patients with hepatolenticular degeneration. Science 1952;116:484-485.
3. Scheinberg IH, Sternlieb I. Major problems in internal medicine. XXIII. Wilson's disease. Philadelphia: WB Saunders; 1984.
4. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GPR. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 1994;87:663-670.
5. Gibbs K, Walshe JM. A study of caeruloplasmin concentrations in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med 1979;48:447-463.
6. Walshe JM, Yealland M. Treatment of neurological Wilson's disease. Q J Med 1993;86:197-204.
7. Kumar N, Gross JB, Ahlskog JE. Copper deficiency myclopathy produces a clinical picture like subacute combined degeneration. Neurology 2004;63:33-39.
8. Hedera P, Fink JK, Bockenstedt PL, Brewer JG. Myeloneuropathy and pancytopoenia due to copper deficiency and high zinc levels of unknown origin. Arch Neurol 2003;60:1303-1306.
9. Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS. CNS demyelination associated with copper deficiency and hyper zincernia. Neurology 2002;59:1453-1456.
10. Walshe JM, Potter G. The pattern of whole body distribution of radioactive copper (64Cu, 67Cu) in Wilson's disease and various control groups. Q J Med 1977:46:445-462.
11. Bielli P, Calabrese L. Structure to function relationships in caeruloplasmin: a "moonlighting" protein. Cell Mol Life Sci 2002;59: 1413-1427.
12. Walshe JM, Cox DW. Effect of treatment of Wilson's disease on natural history of haernachromatosis. Lancet 1998;352:112.
13. Walshe JM, Yealland M. Not Wilson's disease: a review of misdiagnosed cases. Q J Med 1995;88:55-59.
14. Koschinsky ML, Chow BK, Schwartz J, Hammerton JL, MacGillivary RT. Isolation and characterization of a processed gene for human caeruloplasmin. Biochemistry 1987;26:7760-7767.
15. Bull P, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type AT-Pase similar to the Menkes gene. Nature genetics. 1993;5:327-337.
16. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197;271-277.
17. Waldenstrom E, Lagerkvist A, Dahlman T, Westermark K, Landegren U. Efficient detection of mutations in Wilson disease by manifold sequencing. Genomics 1996;37:303-309.
18. Cox DW. Factors influencing serum caeruloplasmin levels in normal individuals. J Lab Clin Med 1966;68:893-904.
19. Edwards CQ, Williams DM, Cartwright GE. Hereditary hypocaeruloplasminemia. Clin Genet. 1979;15:311-316.
20. Morita H, Inoue A, Yanagisawa N. A case with caeruloplasmin deficiency which dementia, ataxia and iron deposition in the brain. Rinsho Shinkeigaku 1992;32:483-487.
21. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda M. Familial apocaeruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987;37:761-767.